This World AIDS Day we invite our partners in South Africa and beyond to stand with South Africa in promoting the “Know your Status” global campaign.
Together we can eliminate HIV.
We give credit to all stakeholders, including government, for their tireless efforts in ensuring that so many South African receive anti-retroviral treatment – as well as the growing number of people who are on preventative medication that can help stop HIV infection.
Gilead Science is privileged to be a partner in South Africa to find sustainable solutions towards the elimination of HIV/AIDS.
In many countries, including South Africa, Gilead works licensing partners to produce and sell high-quality, low-cost generic versions of our HIV/AIDS and viral hepatitis medicines-with innovative models that work where the need is great.
This makes a real difference for million of people - including more than three million South Africa benefiting from the work of Gilead and our partners.
For more than 30 years we have worked to develop medicines that address areas of unmet medical need.
Every day we strive to transform and simplify care for people around the world with life-threatening illnesses.
In addition to HIV/AIDS, our products and pipeline of investigational drug includes treatment for haematology and oncology, liver diseases-as well as inflammatory and respiratory diseases.
Gilead is focused on more than medicines. We put a great deal of efforts and investment in strengthening health system. This involves a range of activities to develop workforce skills, infrastructure and more - in South Africa and across the globe